Normally, this effect is necessary to avoid an inappropriate overreaction, such as an auto-immune disease, in healthy individuals.[10] In patients with cancer, antibody blockade against this receptor such as with pembrolizumab reinvigorates the immune system, allowing it to target and destroy cancer cells.[11] Pembrolizumab is one of a number of closely related therapies dubbed immune checkpoint blockade.